These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 483386)

  • 41. Oxytetracycline concentrations in plasma and lung of healthy and pneumonic calves, using two oxytetracycline preparations.
    Ames TR; Patterson EB
    Am J Vet Res; 1985 Dec; 46(12):2471-3. PubMed ID: 3909863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prevalence of Anaplasma marginale and specific antibodies in new born calves].
    Rey Valeirón C; Aso PM; Coronado A
    Acta Cient Venez; 2003; 54(2):121-6. PubMed ID: 14976783
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of enrofloxacin for the treatment of experimentally-induced bovine anaplasmosis.
    Facury-Filho EJ; de Carvalho AÚ; Ferreira PM; Moura MF; Apolinário BC; Santos Lde P; Ribeiro MF
    Rev Bras Parasitol Vet; 2012; 21(1):32-6. PubMed ID: 22534942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of long acting oxytetracycline and parvaquone in immunisation against East Coast fever by infection and treatment.
    Dolan TT; Linyonyi A; Mbogo SK; Young AS
    Res Vet Sci; 1984 Sep; 37(2):175-8. PubMed ID: 6438743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of experimentally induced Theileria annulata infection on the pharmacokinetics of oxytetracycline in cross-bred calves.
    Kumar R; Malik JK
    Vet Res; 1999; 30(1):75-86. PubMed ID: 10081114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cure of Dermatophilus congolensis infection in cattle by long-acting oxytetracycline.
    Ilemobade AA; Gyang EO; Bida SA; Addo PB
    Res Vet Sci; 1979 Nov; 27(3):302-5. PubMed ID: 542717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of long-acting oxytetracycline for the prevention of tick-borne fever in calves.
    Cranwell MP
    Vet Rec; 1990 Apr; 126(14):334-6. PubMed ID: 2339491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of oxytetracycline and a dithiosemicarbazone in the treatment of bovine anaplasmosis.
    Kuttler KL
    Am J Vet Res; 1971 Sep; 32(9):1349-52. PubMed ID: 5094519
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunization of bovines using a DNA vaccine (pcDNA3.1/MSP1b) prepared from the Jaboticabal strain of Anaplasma marginale.
    de Andrade GM; Machado RZ; Vidotto MC; Vidotto O
    Ann N Y Acad Sci; 2004 Oct; 1026():257-66. PubMed ID: 15604503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunity to bovine anaplasmosis after elimination of the carrier status with oxytetracycline hydrochloride.
    Renshaw HW; Magonigle RA; Eckblad WP; Frank FW
    Proc Annu Meet U S Anim Health Assoc; 1976; (80):79-88. PubMed ID: 1078098
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of Moraxella bovis infections in calves using a long-acting oxytetracycline formulation.
    George LW; Smith JA
    J Vet Pharmacol Ther; 1985 Mar; 8(1):55-61. PubMed ID: 3989901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morphologic alteration of Anaplasma marginale in calves treated with a dithiosemicarbazone.
    Simpson CF; Neal FC
    Am J Vet Res; 1982 Nov; 43(11):1903-6. PubMed ID: 7181188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An evaluation of the relative efficacy of a new formulation of oxytetracycline for the treatment of undifferentiated fever in feedlot calves in western Canada.
    Schunicht OC; Booker CW; Guichon PT; Jim GK; Wildman BK; Hill BW; Ward TI; Bauck SW
    Can Vet J; 2002 Dec; 43(12):940-5. PubMed ID: 12561688
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis.
    Kuttler KL
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1103-8. PubMed ID: 7216881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of terramycin/LA-200 administered during the prepatent period of anaplasmosis.
    Eckblad WP; Lincoln SD; Magonigle RA
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):44-52. PubMed ID: 298933
    [No Abstract]   [Full Text] [Related]  

  • 56. Study of an attenuated Anaplasma marginale vaccine in Mexico natural challenge of immunity in an enzootic area.
    Osorno MB; Solana PM; Perez JM; Lopez TR
    Am J Vet Res; 1975 May; 36(5):631-3. PubMed ID: 1137209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of gloxazone, an effective but toxic anaplasmacide, with imidocarb dihydrochloride.
    McHardy N; Berger J; Taylor RJ; Farebrother D; James JA
    Res Vet Sci; 1980 Sep; 29(2):198-202. PubMed ID: 6451008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamics of Anaplasma marginale in splenectomised calves treated with either imidocarb or oxytetracycline.
    Kuttler KL
    Trop Anim Health Prod; 1986 May; 18(2):91-6. PubMed ID: 3739000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Radioimmunoassay for Anaplasma marginale antibodies in cattle.
    Schuntner CA; Leatch G
    Am J Vet Res; 1988 Apr; 49(4):504-7. PubMed ID: 3377309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Concomitant infection of cattle with the vaccine strain Anaplasma marginale ss centrale and field strains of A. marginale.
    Shkap V; Leibovitz B; Krigel Y; Molad T; Fish L; Mazuz M; Fleiderovitz L; Savitsky I
    Vet Microbiol; 2008 Aug; 130(3-4):277-84. PubMed ID: 18387757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.